420(top 100%)
PR articles
14.6K(top 1%)
PR citations
63(top 100%)
PR h-index
69(top 100%)
h-index
448
documents
18.0K
doc citations
2.1K
citing journals
100
times ranked

Publications

420 PR articles • 14,915 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Peptide–Platinum(IV) Conjugation Minimizes the Negative Impact of Current Anticancer Chemotherapy on Nonmalignant Cells
Journal of Medicinal Chemistry, 2023, 66, 3348-3355
5.613Citations (PDF)
2Proteomic tools for the quantitative analysis of artificial peptide libraries: detection and characterization of target‐amplified PD‐1 inhibitors.
ChemBioChem, 2022, ,
2.64Citations (PDF)
3Brain metastasis models: What should we aim to achieve better treatments?15.624Citations (PDF)
4Adrenergic Modulation With Photochromic Ligands
Angewandte Chemie, 2021, 133, 3669-3675
1.47Citations (PDF)
5Adrenergic Modulation With Photochromic Ligands14.449Citations (PDF)
6Target-templated <i>de novo</i> design of macrocyclic <scp>d</scp>-/<scp>l</scp>-peptides: discovery of drug-like inhibitors of PD-1
Chemical Science, 2021, 12, 5164-5170
7.122Citations (PDF)
7Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma
ACS Applied Nano Materials, 2021, 4, 1314-1329
5.322Citations (PDF)
8The Combined Use of Gold Nanoparticles and Infrared Radiation Enables Cytosolic Protein Delivery
Chemistry - A European Journal, 2021, 27, 4670-4675
3.47Citations (PDF)
9Oligoarginine Peptide Conjugated to BSA Improves Cell Penetration of Gold Nanorods and Nanoprisms for Biomedical Applications
Pharmaceutics, 2021, 13, 1204
5.115Citations (PDF)
10<i>In vivo</i> micro computed tomography detection and decrease in amyloid load by using multifunctionalized gold nanorods: a neurotheranostic platform for Alzheimer's disease
Biomaterials Science, 2021, 9, 4178-4190
5.723Citations (PDF)
11NIR and glutathione trigger the surface release of methotrexate linked by Diels-Alder adducts to anisotropic gold nanoparticles5.817Citations (PDF)
12Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon Resonance
Pharmaceuticals, 2020, 13, 134
4.47Citations (PDF)
13Bottom-Up Design Approach for OBOC Peptide Libraries
Molecules, 2020, 25, 3316
4.37Citations (PDF)
14Photoswitchable dynasore analogs to control endocytosis with light
Chemical Science, 2020, 11, 8981-8988
7.16Citations (PDF)
15Amphiphilic Polymeric Nanoparticles Modified with a Retro-Enantio Peptide Shuttle Target the Brain of Mice
Chemistry of Materials, 2020, 32, 7679-7693
6.725Citations (PDF)
16Self‐Assembly of DNA–Peptide Supermolecules: Coiled‐Coil Peptide Structures Templated by <scp>d</scp>‐DNA and <scp>l</scp>‐DNA Triplexes Exhibit Chirality‐Independent but Orientation‐Dependent Stabilizing Cooperativity
Chemistry - A European Journal, 2020, 26, 5676-5684
3.412Citations (PDF)
17Targeted Nanoswitchable Inhibitors of Protein–Protein Interactions Involved in Apoptosis
ChemMedChem, 2019, 14, 100-106
3.18Citations (PDF)
18Protein Chemical Synthesis Combined with Mirror‐Image Phage Display Yields <scp>d</scp>‐Peptide EGF Ligands that Block the EGF–EGFR Interaction
ChemBioChem, 2019, 20, 2079-2084
2.621Citations (PDF)
19A Third Shot at EGFR: New Opportunities in Cancer Therapy11.897Citations (PDF)
20Enthalpy‐ versus Entropy‐Driven Molecular Recognition in the Era of Biologics
ChemBioChem, 2019, 20, 2981-2986
2.67Citations (PDF)
21Expanding the MiniAp‐4 BBB‐shuttle family: Evaluation of proline <i>cis</i>‐<i>trans</i> ratio as tool to fine‐tune transport2.08Citations (PDF)
22A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles—Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models3.59Citations (PDF)
23Algorithm-supported, mass and sequence diversity-oriented random peptide library design5.515Citations (PDF)
24Lebetin Peptides, A New Class of Potent Platelet Aggregation Inhibitors: Chemical Synthesis, Biological Activity and NMR Spectroscopic Study2.23Citations (PDF)
25Trimeric heptad repeat synthetic peptides HR1 and HR2 efficiently inhibit HIV-1 entry
Bioscience Reports, 2019, 39,
4.09Citations (PDF)
26PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy
Journal of Controlled Release, 2018, 276, 125-139
11.188Citations (PDF)
27‘À La Carte’ Cyclic Hexapeptides: Fine Tuning Conformational Diversity while Preserving the Peptide Scaffold.
ChemistrySelect, 2018, 3, 2343-2351
1.70Citations (PDF)
28Increased immune cell infiltration in patient-derived tumor explants treated with Traniplatin: an original Pt(<scp>iv</scp>) pro-drug based on Cisplatin and Tranilast
Chemical Communications, 2018, 54, 8324-8327
3.419Citations (PDF)
29Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides3.535Citations (PDF)
30Bromotryptophans and their incorporation in cyclic and bicyclic privileged peptides
Biopolymers, 2018, 109,
2.913Citations (PDF)
31Toward a Novel Drug To Target the EGF–EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides
ChemBioChem, 2018, 19, 76-84
2.628Citations (PDF)
32From venoms to BBB-shuttles. MiniCTX3: a molecular vector derived from scorpion venom
Chemical Communications, 2018, 54, 12738-12741
3.428Citations (PDF)
33HAI Peptide and Backbone Analogs—Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles3.511Citations (PDF)
34Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood–brain barrier transport
Chemical Science, 2018, 9, 8409-8415
7.150Citations (PDF)
35Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic Approach
Current Pharmaceutical Design, 2018, 24, 1366-1376
2.436Citations (PDF)
36Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms
Angewandte Chemie, 2018, 130, 14039-14043
1.42Citations (PDF)
37Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms14.421Citations (PDF)
38Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics
Cell Chemical Biology, 2018, 25, 1031-1037.e4
6.248Citations (PDF)
39<scp>d</scp>‐Polyarginine Lipopeptides as Intestinal Permeation Enhancers
ChemMedChem, 2018, 13, 2045-2052
3.119Citations (PDF)
40Blood–brain barrier peptide shuttles5.955Citations (PDF)
41Bike peptides: a ride through the membrane
Journal of Peptide Science, 2017, 23, 294-302
2.09Citations (PDF)
42The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia1.121Citations (PDF)
43Improving Gold Nanorod Delivery to the Central Nervous System By Conjugation to the Shuttle Angiopep-2
Nanomedicine, 2017, 12, 2503-2517
3.146Citations (PDF)
44Jumping Hurdles: Peptides Able To Overcome Biological Barriers
Accounts of Chemical Research, 2017, 50, 1847-1854
17.171Citations (PDF)
45Combating virulence of Gram-negative bacilli by OmpA inhibition3.579Citations (PDF)
46Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease3.773Citations (PDF)
47Measuring the Spin‐Polarization Power of a Single Chiral Molecule
Small, 2017, 13,
11.6171Citations (PDF)
48Phage display as a tool to discover blood–brain barrier (<scp>BBB</scp>)‐shuttle peptides: panning against a human <scp>BBB</scp> cellular model
Biopolymers, 2017, 108,
2.927Citations (PDF)
49The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer
Molecules, 2017, 22, 198
4.34Citations (PDF)
50Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity
Molecules, 2017, 22, 1929
4.3272Citations (PDF)
51Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac
PLoS ONE, 2016, 11, e0160973
2.418Citations (PDF)
52Peptides Targeting EGF Block the EGF–EGFR Interaction
ChemBioChem, 2016, 17, 702-711
2.623Citations (PDF)
53Synthesis of an Orthogonally Protected Polyhydroxylated Cyclopentene from <scp>l</scp>‐Sorbose
Chemistry - an Asian Journal, 2016, 11, 2035-2040
3.02Citations (PDF)
54MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery14.482Citations (PDF)
55Innentitelbild: MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery (Angew. Chem. 2/2016)
Angewandte Chemie, 2016, 128, 464-464
1.40Citations (PDF)
56Blood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Chemical Society Reviews, 2016, 45, 4690-4707
37.8394Citations (PDF)
57MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery
Angewandte Chemie, 2016, 128, 582-585
1.49Citations (PDF)
58Using peptides to increase transport across the intestinal barrier
Advanced Drug Delivery Reviews, 2016, 106, 355-366
15.641Citations (PDF)
59Analyzing slowly exchanging protein conformations by ion mobility mass spectrometry: study of the dynamic equilibrium of prolyl oligopeptidase
Journal of Mass Spectrometry, 2016, 51, 504-511
1.77Citations (PDF)
60Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor
ChemMedChem, 2016, 11, 928-939
3.110Citations (PDF)
61Active‐Site‐Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics
ChemBioChem, 2016, 17, 913-917
2.618Citations (PDF)
62Chemical Composition and Inhibitory Effects of Hypericum brasiliense and H. connatum on Prolyl Oligopeptidase and Acetylcholinesterase Activities
Medicinal Chemistry, 2016, 12, 457-463
2.23Citations (PDF)
63Josef Rudinger Memorial Lecture: Use of peptides to modulate protein-protein interactions
Journal of Peptide Science, 2015, 21, 447-453
2.00Citations (PDF)
64Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches5.868Citations (PDF)
65Lipid Bilayer Crossing—The Gate of Symmetry. Water-Soluble Phenylproline-Based Blood-Brain Barrier Shuttles15.049Citations (PDF)
66An optimized method for 15N R1 relaxation rate measurements in non-deuterated proteins
Journal of Biomolecular NMR, 2015, 62, 209-220
1.521Citations (PDF)
67Three Valuable Peptides from Bee and Wasp Venoms for Therapeutic and Biotechnological Use: Melittin, Apamin and Mastoparan
Toxins, 2015, 7, 1126-1150
3.9307Citations (PDF)
68Unveiling Prolyl Oligopeptidase Ligand Migration by Comprehensive Computational Techniques
Biophysical Journal, 2015, 108, 116-125
2.223Citations (PDF)
69Applying the Retro‐Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood–Brain Barrier14.4111Citations (PDF)
70Absence of a Stable Secondary Structure Is Not a Limitation for Photoswitchable Inhibitors of β-Arrestin/β-Adaptin 2 Protein-Protein Interaction
Chemistry and Biology, 2015, 22, 31-37
4.822Citations (PDF)
71Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii5.524Citations (PDF)
72A new quinoxaline-containing peptide induces apoptosis in cancer cells by autophagy modulation
Chemical Science, 2015, 6, 4537-4549
7.122Citations (PDF)
73Applying the Retro‐Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood–Brain Barrier
Angewandte Chemie, 2015, 127, 4039-4044
1.47Citations (PDF)
74Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from <i>Psychotria solitudinum</i>
Journal of Natural Products, 2015, 78, 1073-1082
3.651Citations (PDF)
75CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates4.035Citations (PDF)
76Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant<i>Acinetobacter nosocomialis</i>mutants selected<i>in vitro</i>3.229Citations (PDF)
77‘À la Carte’ Peptide Shuttles: Tools to Increase Their Passage across the Blood–Brain Barrier
ChemMedChem, 2014, 9, 1594-1601
3.126Citations (PDF)
78Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer’s disease13.9120Citations (PDF)
79Delivering wasp venom for cancer therapy11.129Citations (PDF)
80Dual system for the central nervous system targeting and blood‐brain barrier transport of a selective prolyl oligopeptidase inhibitor
Biopolymers, 2013, 100, 662-674
2.99Citations (PDF)
81Light‐Regulated Stapled Peptides to Inhibit Protein–Protein Interactions Involved in Clathrin‐Mediated Endocytosis14.493Citations (PDF)
82Stable Conjugates of Peptides with Gold Nanorods for Biomedical Applications with Reduced Effects on Cell Viability8.071Citations (PDF)
83Electrostatic Binding and Hydrophobic Collapse of Peptide–Nucleic Acid Aggregates Quantified Using Force Spectroscopy
ACS Nano, 2013, 7, 5102-5113
15.327Citations (PDF)
84In Vitro Evaluation of Caffeoyl and Cinnamoyl Derivatives as Potential Prolyl Oligopeptidase Inhibitors
Planta Medica, 2013, 79, 1531-1535
0.510Citations (PDF)
85From venoms to BBB shuttles: Synthesis and blood–brain barrier transport assessment of apamin and a nontoxic analog
Biopolymers, 2013, 100, 675-686
2.948Citations (PDF)
86Peptide Pop Inhibitors for the Treatment of the Cognitive Symptoms of Schizophrenia
Future Medicinal Chemistry, 2013, 5, 1509-1523
2.412Citations (PDF)
87Titelbild: Light-Regulated Stapled Peptides to Inhibit Protein-Protein Interactions Involved in Clathrin-Mediated Endocytosis (Angew. Chem. 30/2013)
Angewandte Chemie, 2013, 125, 7759-7759
1.40Citations (PDF)
88Light‐Regulated Stapled Peptides to Inhibit Protein–Protein Interactions Involved in Clathrin‐Mediated Endocytosis
Angewandte Chemie, 2013, 125, 7858-7862
1.430Citations (PDF)
89Computer-Aided Design of Fragment Mixtures for NMR-Based Screening
PLoS ONE, 2013, 8, e58571
2.415Citations (PDF)
90Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design, 2013, 19, 2924-2942
2.414Citations (PDF)
91Update of Peptides with Antibacterial Activity
Current Medicinal Chemistry, 2012, 19, 6188-6198
2.67Citations (PDF)
92Applications of 3-aminolactams: design, synthesis, and biological evaluation of a library of potential dimerisation inhibitors of HIV1-protease2.62Citations (PDF)
93Solid-phase-assisted synthesis of targeting peptide–PEG–oligo(ethane amino)amides for receptor-mediated gene delivery2.669Citations (PDF)
94In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii5.588Citations (PDF)
95Combined bottom-up and top-down mass spectrometry analyses of the pattern of post-translational modifications of Drosophila melanogaster linker histone H1
Journal of Proteomics, 2012, 75, 4124-4138
2.439Citations (PDF)
96Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor
Biomaterials, 2012, 33, 7194-7205
12.3255Citations (PDF)
97Staple Motifs, Initial Steps in the Formation of Thiolate-Protected Gold Nanoparticles: How Do They Form?
Inorganic Chemistry, 2012, 51, 11422-11429
4.622Citations (PDF)
98Template-Assisted Lateral Growth of Amyloid-β42 Fibrils Studied by Differential Labeling with Gold Nanoparticles
Bioconjugate Chemistry, 2012, 23, 27-32
3.914Citations (PDF)
99Inhibitory Effect of Verbascoside Isolated from <i>Buddleja brasiliensis</i> Jacq. ex Spreng on Prolyl Oligopeptidase Activity
Phytotherapy Research, 2012, 26, 1472-1475
6.421Citations (PDF)
100Update of Peptides with Antibacterial Activity
Current Medicinal Chemistry, 2012, 19, 6188-6198
2.628Citations (PDF)
101Aβ40 and Aβ42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties15.0100Citations (PDF)
102Rational Design of a Selective Covalent Modifier of G Protein βγ Subunits
Molecular Pharmacology, 2011, 79, 24-33
2.710Citations (PDF)
103Electrochemical Investigation of Cellular Uptake of Quantum Dots Decorated with a Proline-Rich Cell Penetrating Peptide
Bioconjugate Chemistry, 2011, 22, 180-185
3.914Citations (PDF)
104On the Role of Flexibility in Protein–Ligand Interactions: the Example of p53 Tetramerization Domain
Chemistry - an Asian Journal, 2011, 6, 1463-1469
3.017Citations (PDF)
105Recent patents of dipeptidyl peptidase IV inhibitors4.026Citations (PDF)
106Improved Fmoc‐based solid‐phase synthesis of homologous peptide fragments of human and mouse prion proteins2.07Citations (PDF)
107Schleuservermittelter Transport von Wirkstoffen ins Gehirn
Angewandte Chemie, 2011, 123, 8148-8165
1.49Citations (PDF)
108Shuttle‐Mediated Drug Delivery to the Brain14.479Citations (PDF)
109Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E)
ChemBioChem, 2011, 12, 896-903
2.673Citations (PDF)
110<sup>15</sup>N Relaxation NMR Studies of Prolyl Oligopeptidase, an 80 kDa Enzyme, Reveal a Pre‐existing Equilibrium between Different Conformational States
ChemBioChem, 2011, 12, 2737-2739
2.625Citations (PDF)
111Direct-reversible binding of small molecules to G protein βγ subunits2.127Citations (PDF)
112A Signaling Mechanism Coupling Netrin-1/Deleted in Colorectal Cancer Chemoattraction to SNARE-Mediated Exocytosis in Axonal Growth Cones
Journal of Neuroscience, 2011, 31, 14463-14480
3.761Citations (PDF)
113Selenomethionine Incorporation into Amyloid Sequences Regulates Fibrillogenesis and Toxicity
PLoS ONE, 2011, 6, e27999
2.417Citations (PDF)
114NMR analysis of G-protein βγ subunit complexes reveals a dynamic Gα-Gβγ subunit interface and multiple protein recognition modes7.625Citations (PDF)
115Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers
Fìtoterapìâ, 2010, 81, 552-556
2.541Citations (PDF)
116Novel Peptidyl Aryl Vinyl Sulfones as Highly Potent and Selective Inhibitors of Cathepsins L and B
ChemMedChem, 2010, 5, 1556-1567
3.132Citations (PDF)
117Fusion Intermediates of HIV‐1 gp41 as Targets for Antibody Production: Design, Synthesis, and HR1–HR2 Complex Purification and Characterization of Generated Antibodies
ChemMedChem, 2010, 5, 1907-1918
3.17Citations (PDF)
118Simultaneous <sup>19</sup>F NMR Screening of Prolyl Oligopeptidase and Dipeptidyl Peptidase IV Inhibitors
ChemBioChem, 2010, 11, 1115-1119
2.616Citations (PDF)
119Molecular recognition at protein surface in solution and gas phase: Five VEGF peptidic ligands show inverse affinity when studied by NMR and CID‐MS
Biopolymers, 2010, 94, 689-700
2.97Citations (PDF)
120Towards the identification of unknown neuropeptide precursor-processing enzymes: Design and synthesis of a new family of dipeptidyl phosphonate activity probes for substrate-based protease identification2.613Citations (PDF)
121Building Cell Selectivity into CPP-Mediated Strategies
Pharmaceuticals, 2010, 3, 1456-1490
4.450Citations (PDF)
122Small Peptide Inhibitors Disrupt a High-Affinity Interaction between Cytoplasmic Dynein and a Viral Cargo Protein
Journal of Virology, 2010, 84, 10792-10801
3.740Citations (PDF)
123Relevant Elements of a Maize γ-Zein Domain Involved in Protein Body Biogenesis
Journal of Biological Chemistry, 2010, 285, 35633-35644
2.256Citations (PDF)
124Improving The Brain Delivery of Gold Nanoparticles by Conjugation with An Amphipathic Peptide
Nanomedicine, 2010, 5, 897-913
3.1112Citations (PDF)
125<i>N</i>-Methyl Phenylalanine-Rich Peptides as Highly Versatile Blood−Brain Barrier Shuttles
Journal of Medicinal Chemistry, 2010, 53, 2354-2363
5.665Citations (PDF)
126Folding and self-assembling with β-oligomers based on (1R,2S)-2-aminocyclobutane-1-carboxylic acid2.666Citations (PDF)
127Structure and Intermolecular Dynamics of Aggregates Populated during Amyloid Fibril Formation Studied by Hydrogen/Deuterium Exchange
Accounts of Chemical Research, 2010, 43, 1072-1079
17.170Citations (PDF)
128Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy
Protein Science, 2009, 18, 481-493
6.026Citations (PDF)
129Exploration of the One-Bead One-Compound Methodology for the Design of Prolyl Oligopeptidase Substrates
PLoS ONE, 2009, 4, e6222
2.48Citations (PDF)
130Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation7.6112Citations (PDF)
131Explicit Treatment of Water Molecules in Protein-Ligand Docking1.019Citations (PDF)
132A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors11.1104Citations (PDF)
133Mechanism of action of and resistance to quinolones
Microbial Biotechnology, 2009, 2, 40-61
5.0405Citations (PDF)
134A new side opening on prolyl oligopeptidase revealed by electron microscopy
FEBS Letters, 2009, 583, 3344-3348
2.717Citations (PDF)
135Shuttling Gold Nanoparticles into Tumoral Cells with an Amphipathic Proline‐Rich Peptide
ChemBioChem, 2009, 10, 1025-1031
2.652Citations (PDF)
136Activity‐Based Probes for Monitoring Postproline Protease Activity
ChemBioChem, 2009, 10, 2361-2366
2.623Citations (PDF)
137A Cost‐Effective Labeling Strategy for the NMR Study of Large Proteins: Selective <sup>15</sup>N‐Labeling of the Tryptophan Side Chains of Prolyl Oligopeptidase
ChemBioChem, 2009, 10, 2736-2739
2.613Citations (PDF)
138Development and Characterization of Peptidic Fusion Inhibitors Derived from HIV‐1 gp41 with Partial <scp>D</scp>‐Amino Acid Substitutions
ChemMedChem, 2009, 4, 570-581
3.122Citations (PDF)
139Retro‐Enantio N‐Methylated Peptides as β‐Amyloid Aggregation Inhibitors
ChemMedChem, 2009, 4, 1488-1494
3.139Citations (PDF)
140Using peptidyl aldehydes in activity-based proteomics2.16Citations (PDF)
141An Intramolecular O−N Migration Reaction on Gold Surfaces: Toward the Preparation of Well-Defined Amyloid Surfaces
ACS Nano, 2009, 3, 3091-3097
15.311Citations (PDF)
142Novel System to Achieve One-Pot Modification of Cargo Molecules with Oligoarginine Vectors for Intracellular Delivery
Bioconjugate Chemistry, 2009, 20, 249-257
3.931Citations (PDF)
143Cytosolic Targeting of Macromolecules Using a pH-Dependent Fusogenic Peptide in Combination with Cationic Liposomes
Bioconjugate Chemistry, 2009, 20, 953-959
3.991Citations (PDF)
144Peptides conjugated to gold nanoparticles induce macrophage activation
Molecular Immunology, 2009, 46, 743-748
2.3134Citations (PDF)
145Homogeneous Conjugation of Peptides onto Gold Nanoparticles Enhances Macrophage Response
ACS Nano, 2009, 3, 1335-1344
15.3153Citations (PDF)
146The role of peptides in blood‐brain barrier nanotechnology
Journal of Peptide Science, 2008, 14, 163-173
2.030Citations (PDF)
147Mechanism of Binding of Fluoroquinolones to the Quinolone Resistance‐Determining Region of DNA Gyrase: Towards an Understanding of the Molecular Basis of Quinolone Resistance
ChemBioChem, 2008, 9, 2081-2086
2.654Citations (PDF)
148<scp>D</scp>‐SAP: A New, Noncytotoxic, and Fully Protease Resistant Cell‐Penetrating Peptide
ChemMedChem, 2008, 3, 296-301
3.155Citations (PDF)
149Benzimidazolium Salts as Small, Nonpeptidic and BBB‐Permeable Human Prolyl Oligopeptidase Inhibitors
ChemMedChem, 2008, 3, 1558-1565
3.120Citations (PDF)
150Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor2.687Citations (PDF)
151Metabolic Cleavage and Translocation Efficiency of Selected Cell Penetrating Peptides: A Comparative Study with Epithelial Cell Cultures
AAPS Journal, 2008, 10, 349-359
3.120Citations (PDF)
152Design and Synthesis of FAJANU: a de Novo<i>C</i><sub>2</sub>Symmetric Cyclopeptide Family
Journal of Medicinal Chemistry, 2008, 51, 3194-3202
5.611Citations (PDF)
153How Changes in the Sequence of the Peptide CLPFFD-NH<sub>2</sub> Can Modify the Conjugation and Stability of Gold Nanoparticles and Their Affinity for β-Amyloid Fibrils
Bioconjugate Chemistry, 2008, 19, 1154-1163
3.9119Citations (PDF)
154Proline-rich, amphipathic cell-penetrating peptides15.6195Citations (PDF)
155Trishomocubane Amino Acid as a β‐turn scaffold3.220Citations (PDF)
156Perspectives on NMR in drug discovery: a technique comes of age82.4399Citations (PDF)
157Structure−Activity Relationship of Kahalalide F Synthetic Analogues
Journal of Medicinal Chemistry, 2008, 51, 4920-4931
5.642Citations (PDF)
158Toward an Optimal Blood−Brain Barrier Shuttle by Synthesis and Evaluation of Peptide Libraries
Journal of Medicinal Chemistry, 2008, 51, 4881-4889
5.663Citations (PDF)
159Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand7.686Citations (PDF)
160Diketopiperazines as a Tool for the Study of Transport across the Blood−Brain Barrier (BBB) and Their Potential Use as BBB-Shuttles15.0104Citations (PDF)
161Self-Assembly of a Cyclobutane β-Tetrapeptide To Form Nanosized Structures
Organic Letters, 2007, 9, 3643-3645
4.885Citations (PDF)
162Redesign of Protein Domains Using One-Bead-One-Compound Combinatorial Chemistry15.09Citations (PDF)
163Disruption of the HIV-1 protease dimer with interface peptides: Structural studies using NMR spectroscopy combined with [2-13C]-Trp selective labeling
Biopolymers, 2007, 88, 164-173
2.931Citations (PDF)
164The Natural Product Berberine is a Human Prolyl Oligopeptidase Inhibitor
ChemMedChem, 2007, 2, 354-359
3.167Citations (PDF)
165Gold nanoparticles for selective and remote heating of β-amyloid protein aggregates5.841Citations (PDF)
166Structural analysis of substance P using molecular dynamics and NMR spectroscopy
Journal of Peptide Science, 2007, 13, 728-741
2.08Citations (PDF)
167Chemical Synthesis of 19F-labeled HIV-1 Protease using Fmoc-Chemistry and ChemMatrix Resin2.220Citations (PDF)
168Does the Solid-Phase Synthesis of a Tetrapeptide Represent a Challenge at the Onset of the XXI Century? The Case of Cyclo [(3R)-3-hydroxydecanoyl-l-seryl-(3R)-3-hydroxydecanoyl-l-seryl]2.22Citations (PDF)
169Differentiation Restricted Endocytosis of Cell Penetrating Peptides in MDCK Cells Corresponds with Activities of Rho-GTPases
Pharmaceutical Research, 2007, 24, 628-642
3.854Citations (PDF)
170Convergent Approaches for the Synthesis of the Antitumoral Peptide, Kahalalide F. Study of Orthogonal Protecting Groups
Journal of Organic Chemistry, 2006, 71, 7196-7204
3.529Citations (PDF)
171IB-01212, a New Cytotoxic Cyclodepsipeptide Isolated from the Marine FungusClonostachyssp. ESNA-A009
Journal of Organic Chemistry, 2006, 71, 3335-3338
3.554Citations (PDF)
172Total Solid-Phase Synthesis of Marine Cyclodepsipeptide IB-01212
Journal of Organic Chemistry, 2006, 71, 3339-3344
3.523Citations (PDF)
173Microwave‐Assisted Solvent‐Free Regiospecific Synthesis of 5‐Alkylidene and 5‐Arylidenehydantoins
Synthetic Communications, 2006, 36, 1575-1584
1.712Citations (PDF)
174Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria4.028Citations (PDF)
175Replacement of a Proline with Silaproline Causes a 20-Fold Increase in the Cellular Uptake of a Pro-Rich Peptide15.073Citations (PDF)
176Efficient Preparation of ProlineN-Carboxyanhydride Using Polymer-Supported Bases
Organic Letters, 2006, 8, 5385-5388
4.819Citations (PDF)
177Mechanistic aspects of CPP-mediated intracellular drug delivery: Relevance of CPP self-assembly2.2205Citations (PDF)
178Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii
Proteomics, 2006, 6, S82-S87
3.132Citations (PDF)
179Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution2.09Citations (PDF)
180A fast and robust 19F NMR-based method for finding new HIV-1 protease inhibitors2.127Citations (PDF)
181Rational Dissection of Binding Surfaces for Mimicking of Discontinuous Antigenic Sites
Chemistry and Biology, 2006, 13, 815-823
4.89Citations (PDF)
182Nanoparticle-Mediated Local and Remote Manipulation of Protein Aggregation
Nano Letters, 2006, 6, 110-115
8.7314Citations (PDF)
183Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line
Investigational New Drugs, 2006, 25, 21-29
2.715Citations (PDF)
184Drosophila dSAP18 is a nuclear protein that associates with chromosomes and the nuclear matrix, and interacts with pinin, a protein factor involved in RNA splicing
Chromosome Research, 2006, 14, 515-526
2.314Citations (PDF)
185Identification by 19F NMR of Traditional Chinese Medicinal Plants Possessing Prolyl Oligopeptidase Inhibitory Activity
ChemBioChem, 2006, 7, 827-833
2.641Citations (PDF)
186Synthetic Ligands Able to Interact with the P53 Tetramerization Domain. Towards Understanding a Protein Surface Recognition Event
ChemBioChem, 2006, 7, 1105-1113
2.616Citations (PDF)
187Evolutionary computation and multimodal search: A good combination to tackle molecular diversity in the field of peptide design
Molecular Diversity, 2006, 11, 7-21
2.918Citations (PDF)
188Design of enhanced agonists through the use of a new virtual screening method: Application to peptides that bind class I major histocompatibility complex (MHC) molecules
Protein Science, 2005, 14, 2069-2079
6.09Citations (PDF)
189Stereogenic Centers and Axes: A Comparison of the Chiral Topologies Available to Cabcd and abC=C=Ccd2.94Citations (PDF)
190AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-κB survival pathway
Leukemia, 2005, 19, 572-579
10.444Citations (PDF)
191Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells
Biochemical Pharmacology, 2005, 71, 32-41
5.223Citations (PDF)
192Synthesis and screening of a small library of proline-based biodendrimers for use as delivery agents
Biopolymers, 2005, 80, 800-814
2.929Citations (PDF)
193ENPDA: an evolutionary structure-based de novo peptide design algorithm2.540Citations (PDF)
194Primary structure, recombinant expression and homology modelling of human brain prolyl oligopeptidase, an important therapeutic target in the treatment of neuropsychiatric diseases
Journal of Peptide Science, 2005, 11, 283-287
2.016Citations (PDF)
195Evolutionary combinatorial chemistry, a novel tool for SAR studies on peptide transport across the blood-brain barrier. Part 2. Design, synthesis and evaluation of a first generation of peptides
Journal of Peptide Science, 2005, 11, 789-804
2.018Citations (PDF)
196Fine structure study of Aβ 1–42 fibrillogenesis with atomic force microscopy
FASEB Journal, 2005, 19, 1344-1346
0.7144Citations (PDF)
197Relationship between Mutations in the gyrA Gene and Quinolone Resistance in Clinical Isolates of Corynebacterium striatum and Corynebacterium amycolatum4.264Citations (PDF)
198Old and New Strategies for the Discovery of Antibacterial Agents0.66Citations (PDF)
199DNA Interaction and Dual Topoisomerase I and II Inhibition Properties of the Anti-Tumor Drug Prodigiosin
Toxicological Sciences, 2005, 85, 870-879
3.891Citations (PDF)
200Coupe du Roi Bisection of Proteins. Spontaneous Tetramerization of Two Peptides That Span the Sequence of the Rabbit Uteroglobin Monomer15.04Citations (PDF)
201Cell-Penetratingcis-γ-Amino-l-Proline-Derived Peptides15.0106Citations (PDF)
202Preparation ofde NovoGlobular Proteins Based on Proline Dendrimers
Journal of Organic Chemistry, 2005, 70, 6274-6281
3.523Citations (PDF)
203Highly Efficient, Nonpeptidic Oligoguanidinium Vectors that Selectively Internalize into Mitochondria15.0128Citations (PDF)
204The GAGA Protein of Drosophila is Phosphorylated by CK2
Journal of Molecular Biology, 2005, 351, 562-572
4.217Citations (PDF)
205Decoding the Entry of Two Novel Cell-Penetrating Peptides in HeLa Cells:  Lipid Raft-Mediated Endocytosis and Endosomal Escape†
Biochemistry, 2005, 44, 72-81
2.4131Citations (PDF)
206Peptide and Amide Bond-Containing Dendrimers
Chemical Reviews, 2005, 105, 1663-1682
52.7345Citations (PDF)
207Evolutionary algorithms and de novo peptide design
Soft Computing, 2005, 10, 295-304
2.512Citations (PDF)
208Computational study of the conformational preferences of the(R)-8-amino-pentacyclo[5.4.0.02,6.03,10.05,9] undecane-8-carboxylic acid monopeptide
Journal of Peptide Science, 2004, 10, 274-284
2.018Citations (PDF)
209Title is missing!1.819Citations (PDF)
210A Tetraguanidinium Ligand Binds to the Surface of the Tetramerization Domain of Protein P5314.437Citations (PDF)
211Potential Peptide Carriers: Amphipathic Proline-Rich Peptides Derived from the N-Terminal Domain ofγ-Zein14.4151Citations (PDF)
212Exploring the interaction of the surfactant N-terminal domain of γ-Zein with soybean phosphatidylcholine liposomes
Biopolymers, 2004, 73, 258-268
2.934Citations (PDF)
213Amphipathic peptides and drug delivery
Biopolymers, 2004, 76, 196-203
2.9131Citations (PDF)
214Solid-phase synthesis of second-generation polyproline dendrimers
Biopolymers, 2004, 76, 283-297
2.926Citations (PDF)
215A Tetraguanidinium Ligand Binds to the Surface of the Tetramerization Domain of Protein P53
Angewandte Chemie, 2004, 116, 198-200
1.48Citations (PDF)
216Potential Peptide Carriers: Amphipathic Proline-Rich Peptides Derived from the N-Terminal Domain ofγ-Zein
Angewandte Chemie, 2004, 116, 1847-1850
1.413Citations (PDF)
217An efficient method for the solid-phase synthesis of fluorescently labelled peptides
Tetrahedron Letters, 2004, 45, 6079-6081
1.413Citations (PDF)
21814-Helical Folding in a Cyclobutane-Containing β-Tetrapeptide
Journal of Organic Chemistry, 2004, 69, 5093-5099
3.546Citations (PDF)
219A New Class of Foldamers Based oncis-γ-Amino-l-proline1,215.0100Citations (PDF)
220Arylboronic Acids and Arylpinacolboronate Esters in Suzuki Coupling Reactions Involving Indoles. Partner Role Swapping and Heterocycle Protection
Journal of Organic Chemistry, 2004, 69, 6812-6820
3.582Citations (PDF)
221Synthesis, Conformational Analysis, and Cytotoxicity of Conformationally Constrained Aplidine and Tamandarin A Analogues Incorporating a Spirolactam β-Turn Mimetic
Journal of Medicinal Chemistry, 2004, 47, 5700-5712
5.623Citations (PDF)
222Title is missing!
Plant Molecular Biology, 2003, 51, 877-884
3.211Citations (PDF)
223Complete1H and13C NMR chemical shift assignment ofN1- andN3-alkylnitrohistidines and of 1,4,6,7-tetrahydroimidazo[4,5-b]pyridines1.40Citations (PDF)
224Saturated resins or stress of the resin
Tetrahedron Letters, 2003, 44, 1751-1754
1.415Citations (PDF)
225Development of a Genetic Algorithm to Design and Identify Peptides that can Cross the Blood-Brain Barrier1.419Citations (PDF)
226Solution Structure of the Antitumor Candidate Trunkamide A by 2D NMR and Restrained Simulated Annealing Methods
Journal of Organic Chemistry, 2003, 68, 211-215
3.537Citations (PDF)
227Bicyclic Homodetic Peptide Libraries:  Comparison of Synthetic Strategies for Their Solid-Phase Synthesis
ACS Combinatorial Science, 2003, 5, 760-768
4.724Citations (PDF)
228Synthesis of 3-Aminolactams as X-Gly Constrained Pseudodipeptides and Conformational Study of a Trp-Gly Surrogate
Journal of Organic Chemistry, 2003, 68, 9541-9553
3.523Citations (PDF)
229Synthesis and NMR Structure of P41icf, a Potent Inhibitor of Human Cathepsin L15.024Citations (PDF)
230Tentoxin as a Scaffold for Drug Discovery. Total Solid-Phase Synthesis of Tentoxin and a Library of Analogues
Organic Letters, 2003, 5, 2115-2118
4.823Citations (PDF)
231Constrained Derivatives of Stylostatin 1. 1. Synthesis and Biological Evaluation as Potential Anticancer Agents
Journal of Medicinal Chemistry, 2003, 46, 5825-5833
5.68Citations (PDF)
232Desymmetrization of the Tetrahedron: Stereogenic Centers2.93Citations (PDF)
233Analysis of Conformational Equilibria in Aplidine Using Selective Excitation 2D NMR Spectroscopy and Molecular Mechanics/Dynamics Calculations
Journal of Organic Chemistry, 2003, 68, 9554-9562
3.513Citations (PDF)
234NMR-based methods and strategies for drug discovery37.855Citations (PDF)
235Synthetic Approaches to Multivalent Lipopeptide Dendrimers Containing Cyclic Disulfide Epitopes of Foot-and-Mouth Disease Virus
Bioconjugate Chemistry, 2003, 14, 144-152
3.932Citations (PDF)
236Effects of l- and d-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication
Biochemical Journal, 2002, 366, 863-872
3.94Citations (PDF)
237A New Method for the Preparation of Unprotected Peptides on Biocompatible Resins with Application in Combinatorial Chemistry†
Organic Letters, 2002, 4, 3831-3833
4.815Citations (PDF)
238Spirolactams as Conformationally Restricted Pseudopeptides:  Synthesis and Conformational Analysis
Journal of Organic Chemistry, 2002, 67, 7587-7599
3.546Citations (PDF)
239Peptide Dendrimers Based on Polyproline Helices15.0116Citations (PDF)
240Supramolecular Properties of the Proline-Rich γ-Zein N-Terminal Domain
Biophysical Journal, 2002, 83, 1194-1204
2.253Citations (PDF)
241De Novo Protein Surface Design: Use of Cation-π Interactions to Enhance Binding between anα-Helical Peptide and a Cationic Molecule in 50 % Aqueous Solution
Angewandte Chemie, 2002, 114, 125-127
1.414Citations (PDF)
242De Novo Protein Surface Design: Use of Cation-π Interactions to Enhance Binding between an α-Helical Peptide and a Cationic Molecule in 50 % Aqueous Solution14.456Citations (PDF)
243Branched Poly(proline) Peptides: An Efficient New Approach to the Synthesis of Repetitive Branched Peptides2.315Citations (PDF)
244Functional Mimicry of a Discontinuous Antigenic Site by a Designed Synthetic Peptide
ChemBioChem, 2002, 3, 175-182
2.620Citations (PDF)
245Structural, kinetic and cytotoxicity aspects of 12-28 ?-amyloid protein fragment: a reappraisal
Journal of Peptide Science, 2002, 8, 578-588
2.022Citations (PDF)
246Solid-phase syntheses of N-substituted carbamates. Reaction monitoring by gel-phase 13C NMR using a 13C enriched BAL-linker
Tetrahedron Letters, 2002, 43, 3543-3546
1.417Citations (PDF)
247Title is missing!
Journal of Biomolecular NMR, 2002, 22, 295-296
1.56Citations (PDF)
248Title is missing!0.311Citations (PDF)
249AN IMPROVED SYNTHESIS OF N-[(9-HYDROXYMETHYL)-2-FLUORENYL]SUCCINAMIC ACID (HMFS), A VERSATILE HANDLE FOR THE SOLID-PHASE SYNTHESIS OF BIOMOLECULES
Synthetic Communications, 2001, 31, 225-232
1.721Citations (PDF)
250Solid-Phase Total Synthesis of Trunkamide A1
Journal of Organic Chemistry, 2001, 66, 7568-7574
3.544Citations (PDF)
251Synthesis and Structure Determination of Kahalalide F1,215.0135Citations (PDF)
252Atropisomerism, biphenyls and the Suzuki coupling: peptide antibiotics
Chemical Society Reviews, 2001, 30, 145-157
37.8300Citations (PDF)
253Self-assembly of the amphipathic helix (VHLPPP)8. A mechanism for zein protein body formation11Edited by W. Baumeister
Journal of Molecular Biology, 2001, 312, 907-913
4.252Citations (PDF)
254Antigenicity modulation upon peptide cyclization: application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona
Vaccine, 2001, 19, 3459-3466
3.211Citations (PDF)
255Conformational Analysis of Dehydrodidemnin B (Aplidine) by NMR Spectroscopy and Molecular Mechanics/Dynamics Calculations
Journal of Organic Chemistry, 2001, 66, 4580-4584
3.520Citations (PDF)
256Solid phase synthesis of enantiomerically pure polyhydroxyvalerolactams
Tetrahedron Letters, 2001, 42, 871-873
1.417Citations (PDF)
257One-pot full peptide deprotection in Fmoc-based solid-phase peptide synthesis: methionine sulfoxide reduction with Bu4NBr
Tetrahedron Letters, 2001, 42, 1891-1893
1.422Citations (PDF)
258Inhibition of HIV-2ROD replication in a lymphoblastoid cell line by the α1-antitrypsin Portland variant (α1-PDX) and the decRVKRcmk peptide: comparison with HIV-1LAI
Microbes and Infection, 2001, 3, 1073-1084
2.43Citations (PDF)
259Two short peptides including segments of subunit A ofEscherichia coliDNA gyrase as potential probes to evaluate the antibacterial activity of quinolones2.06Citations (PDF)
260Location of Disulfide bonds in mature α-L;-fucosidase from pea
Journal of Peptide Science, 2001, 7, 305-315
2.07Citations (PDF)
261Solid-Phase Synthesis of Peptides Containing α,β-Didehydroamino Acids2.311Citations (PDF)
262Synthetic Peptides as Functional Mimics of a Viral Discontinuous Antigenic Site
Biologicals, 2001, 29, 265-269
1.48Citations (PDF)
263Novel charged [14]azolophanes: associative behaviour revealed by electrospray ionization
2000, 14, 1014-1016
10Citations (PDF)
264Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility
2000, 13, 5-13
30Citations (PDF)
265Enantioselective synthetic approaches to cyclopropane and cyclobutane β-amino acids: synthesis and structural study of a conformationally constrained β-dipeptide
Tetrahedron: Asymmetry, 2000, 11, 3569-3584
1.664Citations (PDF)
266Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines6.5174Citations (PDF)
267Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies1.523Citations (PDF)
268Molecular analysis of peptides from the GH loop of foot-and-mouth disease virus C-S30 using surface plasmon resonance: a role for kinetic rate constants
Molecular Immunology, 2000, 37, 975-985
2.37Citations (PDF)
269Side chain elongation causes a change from enthalpy driven to entropy driven binding in the molecular recognition of tetraanionic peptides
Chemical Communications, 2000, , 1399-1400
3.419Citations (PDF)
270Oxazolopiperidin-2-ones as Type II‘ β-Turn Mimetics:  Synthesis and Conformational Analysis
Journal of Organic Chemistry, 2000, 65, 6992-6999
3.541Citations (PDF)
2713-Amino-2-piperidones as constrained pseudopeptides: Preparation of a new Ser-Leu surrogate
Tetrahedron Letters, 1999, 40, 4865-4868
1.417Citations (PDF)
272Title is missing!0.34Citations (PDF)
273Title is missing!0.30Citations (PDF)
274An investigation of residue-specific contributions to peptide desorption in MALDI-TOF mass spectrometry0.39Citations (PDF)
275Application of the disulfide trapping approach to explain the antiparallel assembly of dimeric rabbit uteroglobin: A preliminary study using short peptide models0.35Citations (PDF)
276An HPLC-ESMS study on the solid-phase assembly ofC-terminal proline peptides
1999, 5, 131-140
41Citations (PDF)
277Surface plasmon resonance screening of synthetic peptides mimicking the immunodominant region of C-S8c1 foot-and-mouth disease virus
Vaccine, 1999, 18, 362-370
3.226Citations (PDF)
278Molecular dynamics study of kaliotoxin in water8.22Citations (PDF)
279A Rationally Designed Synthetic Peptide Mimic of a Discontinuous Viral Antigenic Site Elicits Neutralizing Antibodies15.06Citations (PDF)
280Surface Recognition and Helix Stabilization of a Tetraaspartate Peptide by Shape and Electrostatic Complementarity of an Artificial Receptor15.048Citations (PDF)
281Active carbonate resins: Application to the solid-phase synthesis of alcohol, carbamate and cyclic peptides
Tetrahedron, 1998, 54, 10125-10152
2.049Citations (PDF)
282Reduction of methionine sulfoxide with : Compatibility with peptides containing cysteine and aromatic amino acids
Tetrahedron, 1998, 54, 15273-15286
2.034Citations (PDF)
283An Easy Entry to a New High-Symmetry, Large Molecular Framework for Molecular Recognition Studies and de Novo Protein Design. Solvent Modulation of the Spontaneous Formation of a Cyclic Monomer, Dimer, or Trimer from a Bis-cysteine Peptide15.017Citations (PDF)
284Recognition and Stabilization of an α-Helical Peptide by a Synthetic Receptor15.096Citations (PDF)
285Synthesis and Antitumor Evaluation of New Thiazolo[5,4-b]quinoline Derivatives5.641Citations (PDF)
286A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic site of foot-and-mouth disease virus8.214Citations (PDF)
287Total Synthesis of Dehydrodidemnin B. Use of Uronium and Phosphonium Salt Coupling Reagents in Peptide Synthesis in Solution
Journal of Organic Chemistry, 1997, 62, 354-366
3.587Citations (PDF)
288Title is missing!0.30Citations (PDF)
289Title is missing!0.31Citations (PDF)
290D-Amino acids in protein de novo design. II. Protein-diastereomerism versus protein-enantiomerism0.311Citations (PDF)
291Temperature coefficients of peptides dissolved in hexafluoroisopropanol monitor distortions of helices0.37Citations (PDF)
292The use of the Nbb-resin for the solid-phase synthesis of peptide alkylesters and alkylamides. Synthesis of leuprolide
Tetrahedron, 1997, 53, 3179-3194
2.021Citations (PDF)
293Synthetic studies on threonines. The preparation of protected derivatives of d-allo- and l-allo-threonine for peptide synthesis
Tetrahedron, 1997, 53, 3369-3382
2.011Citations (PDF)
294Simple methods for the preparation of protected derivatives of and
Tetrahedron Letters, 1997, 38, 299-302
1.45Citations (PDF)
295Active carbonate resins for solid-phase synthesis through the anchoring of a hydroxyl function. Synthesis of cyclic and alcohol peptides
Tetrahedron Letters, 1997, 38, 883-886
1.462Citations (PDF)
296A new approach to Hmb-backbone protection of peptides: Synthesis and reactivity of Nα-Fmoc-Nα-(Hmb)amino acids
Tetrahedron Letters, 1997, 38, 2317-2320
1.436Citations (PDF)
297Use of Alloc-amino acids in solid-phase peptide synthesis. Tandem deprotection-coupling reactions using neutral conditions
Tetrahedron Letters, 1997, 38, 7275-7278
1.4172Citations (PDF)
298Structural comparison in solution of a native and retro peptide derived from the third helix ofStaphylococcus aureus protein A, domain B: retro peptides, a useful tool for the discrimination of helix stabilization factors dependent on the peptide chain orientation
Journal of Peptide Science, 1997, 3, 299-313
2.013Citations (PDF)
2993D structure of kaliotoxin: is residue 34 a key for channel selectivity?
1997, 3, 314-319
33Citations (PDF)
300Anion Helicates:  Double Strand Helical Self-Assembly of Chiral Bicyclic Guanidinium Dimers and Tetramers around Sulfate Templates15.0225Citations (PDF)
301Convergent Synthesis of Repeating Peptides (Val-X-Leu-Pro-Pro-Pro)8 Adopting a Polyproline II Conformation
Journal of Organic Chemistry, 1996, 61, 6775-6782
3.527Citations (PDF)
302Synthesis of 3-Amino-4-indolyl-2-piperidones: Tryptophan-derived Pseudodipeptides
Heterocycles, 1996, 43, 513
0.413Citations (PDF)
303Synthesis of derivatives of (2S,4S)-4-hydroxy-2,5-dimethyl-3-oxohexanoic acid, a constituent of the didemnins1.04Citations (PDF)
304Structural limitations to antigenic mimicry achievable with retroinverso (all-D-retro) peptides
Trends in Biotechnology, 1996, 14, 44-45
8.926Citations (PDF)
305Analysis of the conformational preferences of (4R,5R)-4,5-bis(alkylcarbamoyl)-1,3-dioxolanes
Tetrahedron, 1996, 52, 8275-8286
2.08Citations (PDF)
306Use of N-tritylamino acids and PyAOP1 for the suppression of diketopiperazine formation in Fmoc/tBu solid-phase peptide synthesis using alkoxybenzyl ester anchoring linkages
Tetrahedron Letters, 1996, 37, 4195-4198
1.467Citations (PDF)
307Solid phase-mediated cyclization of head-to-tail peptides: Problems associated with side chain anchoring
Tetrahedron Letters, 1996, 37, 4229-4232
1.424Citations (PDF)
308CD studies of peptides that mimic the four helicoidal sequences of the uteroglobin monomer0.33Citations (PDF)
309Conformationally Restricted Analogues of Tryptophan: Synthesis of Chiral 3-Amino-4-indolyl-2-piperidones
Synthetic Communications, 1996, 26, 3029-3059
1.714Citations (PDF)
310Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host
Virology, 1995, 206, 298-306
2.393Citations (PDF)
311Molecular evolution of aphthoviruses
Virus Genes, 1995, 11, 197-207
1.938Citations (PDF)
312Solutionversus solid-phase cyclization strategies for large sidechain lactam-bridged peptides: A comparative study
Journal of Peptide Science, 1995, 1, 241-250
2.09Citations (PDF)
313Synthesis and applications of a new base-labile fluorene derived linker for solid-phase peptide synthesis
Tetrahedron, 1995, 51, 1449-1458
2.042Citations (PDF)
314A study of the use of NH4I for the reduction of methionine sulfoxide in peptides containing cysteine and cystine
Tetrahedron, 1995, 51, 5701-5710
2.052Citations (PDF)
315Cyclization of a large disulfide peptide in the solid phase
Tetrahedron Letters, 1995, 36, 1137-1140
1.412Citations (PDF)
316Boc-S-methylbenzyl-(S)-2-amino-6-mercaptohexanoic acid: Preparation and application to the synthesis of a large cyclic disulfide peptide
Tetrahedron Letters, 1995, 36, 3885-3888
1.45Citations (PDF)
317Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction.
EMBO Journal, 1995, 14, 1690-1696
7.4173Citations (PDF)
318Convergent Solid Phase Peptide Synthesis: An Efficient Approach to the Synthesis of Highly Repetitive Protein Domains
Journal of Organic Chemistry, 1995, 60, 7575-7581
3.529Citations (PDF)
319S-Phenylacetamidomethyl (Phacm): an orthogonal cysteine protecting group for Boc and Fmoc solid-phase peptide synthesis strategies1.040Citations (PDF)
320Convergent solid‐phase peptide synthesis 12. * Chromatographic techniques for the purification of protected peptide segments0.19Citations (PDF)
321Examining the relationship between secondary structure and antibody recognition in immunopeptides from foot-and-mouth disease virus0.35Citations (PDF)
322Solid-phase synthesis of peptides using allylic anchoring groups 2. Palladium-catalysed cleavage of Fmoc-protected peptides
Tetrahedron Letters, 1994, 35, 4437-4440
1.432Citations (PDF)
323Severe side-reaction in the acidolytic cleavage of a C-terminal Met-containing peptide from the solid support. Formation of the homoserine lactone peptide
Tetrahedron Letters, 1994, 35, 175-178
1.49Citations (PDF)
324Solid-phase synthesis of “head-to-tail” cyclic peptides via lysine side-chain anchoring
Tetrahedron Letters, 1994, 35, 9633-9636
1.482Citations (PDF)
325Kaliotoxin (1-37) Shows Structural Differences With Related Potassium Channel Blockers
Biochemistry, 1994, 33, 14256-14263
2.458Citations (PDF)
326Synthesis of D-alloisoleucine from L-isoleucine and from (S)-2-methylbutan-1-ol. Synthesis of isostatine1.024Citations (PDF)
327Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs4.2266Citations (PDF)
328Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites
Journal of Virology, 1994, 68, 1407-1417
3.7118Citations (PDF)
329CD of proline-rich polypeptides: Application to the study of the repetitive domain of maize glutelin-2
Biopolymers, 1993, 33, 1019-1028
2.9172Citations (PDF)
330Convergent solid-phase peptide synthesis. XI. Synthesis and purification of protected peptide segments spanning the entire sequence of the uteroglobin monomer using the photolabile nbb-resin.
Tetrahedron, 1993, 49, 10069-10078
2.016Citations (PDF)
331Convergent solid-phase peptide synthesis
Tetrahedron, 1993, 49, 11065-11133
2.0208Citations (PDF)
332Gel-phase 31P-NMR. A new analytical tool to evaluate solid phase oligonucleoside synthesis.2.126Citations (PDF)
333Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus
FEBS Letters, 1993, 330, 253-259
2.733Citations (PDF)
334Cyclic disulfide model of the major antigenic site of serotype-C foot-and-mouth disease virus
FEBS Letters, 1993, 328, 159-164
2.717Citations (PDF)
335Design, synthesis, and complexing properties of (1Cys-1'Cys,4Cys-4'Cys)-dithiobis(Ac-L-1Cys-L-Pro-D-Val-L-4Cys-NH2). The first example of a new family of ion-binding peptides15.027Citations (PDF)
336Unequivocal synthesis and characterization of a parallel and an antiparallel bis-cystine peptide
Journal of Organic Chemistry, 1993, 58, 6319-6328
3.513Citations (PDF)
337Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection
Journal of Virology, 1993, 67, 6071-6079
3.7118Citations (PDF)
338Conformational Study of a Nine Residue Fragment of the Antigenic Loop of Foot-and-Mouth Disease Virus2.810Citations (PDF)
339Reversible protection of lysine to facilitate the purification of protected peptide segments
Tetrahedron Letters, 1992, 33, 397-400
1.49Citations (PDF)
340S-2-(2,4-dinitrophenyl)ethyl--cysteine: a new derivative for solid-phase peptide synthesis
Tetrahedron Letters, 1992, 33, 2391-2394
1.415Citations (PDF)
341A new flourene-derived anchor for solid-phase synthesis of protected peptides
Tetrahedron Letters, 1992, 33, 1775-1778
1.428Citations (PDF)
342Synthesis and ion-binding properties of an immobilized bis-cysteine peptide2.10Citations (PDF)
343A new approach to the solid-phase peptide synthesis of peptide alkyl-amides and esters
Tetrahedron Letters, 1992, 33, 2183-2186
1.411Citations (PDF)
344Non-additive effects of multiple amino acid substitutions on antigen-antibody recognition
European Journal of Immunology, 1992, 22, 1385-1389
3.236Citations (PDF)
345Studies on antigenic variability of C strains of foot‐and‐mouth disease virus by means of synthetic peptides and monoclonal antibodies0.142Citations (PDF)
346A new ionizable chromophore of 1,4-bis(alkylamino)benzo[g]phthalazine which interacts with DNA by intercalation5.622Citations (PDF)
347Determination of interchain NOEs in symmetrical dimer peptides15.06Citations (PDF)
348NPE-resin, a new approach to the solid-phase synthesis of protected peptides and oligonucleotides I : Synthesis of the supports and their application to oligonucleotide synthesis.
Tetrahedron Letters, 1991, 32, 1511-1514
1.444Citations (PDF)
349NPE-resin, a new approach to the solid-phase synthesis of protected peptides and oligonucleotides II. Synthesis of protected peptides
Tetrahedron Letters, 1991, 32, 1515-1518
1.431Citations (PDF)
350Conformational analysis of bacitracin A, a naturally occurring lariat
Biopolymers, 1991, 31, 605-612
2.99Citations (PDF)
351Conformational analysis of two cyclic disulfide peptides
Biopolymers, 1991, 31, 835-843
2.910Citations (PDF)
352Determination of the enantiomeric purity of synthetic peptides by gas chromatography—mass spectrometry
Biomedical Applications, 1991, 562, 447-458
1.910Citations (PDF)
353Solid-phase synthesis of peptides using allylic anchoring groups. An investigation of their palladium-catalysed cleavage
Tetrahedron Letters, 1991, 32, 4207-4210
1.451Citations (PDF)
354Convergent solid-phase peptide synthesis. X. Synthesis and purification of protected peptide fragments using the photolabile Nbb-resin
Tetrahedron, 1991, 47, 9867-9880
2.027Citations (PDF)
355Preparation of oligonucleotides containing dAICA using an unexpected side-reaction observed on a protected derivative of 2-aza-2′-deoxyinosine.
Tetrahedron, 1991, 47, 8917-8930
2.014Citations (PDF)
356Synthesis of defined peptide-oligonucleotide hybrids containing a nuclear transport signal sequence.
Tetrahedron, 1991, 47, 4113-4120
2.086Citations (PDF)
357Convergent solid‐phase peptide synthesis0.125Citations (PDF)
358Cyclization of disulfide‐containing peptides in solid‐phase synthesis<sup>†</sup>0.198Citations (PDF)
359Use of BOP reagent for the suppression of diketopiperazine formation in boc/bzl solid-phase peptide synthesis
Tetrahedron Letters, 1990, 31, 7363-7366
1.461Citations (PDF)
360Polysytyrene-supported synthesis by the phosphite triester approach: An alternative for the large scale synthesis of small oligodeoxyribonucleotides.
Tetrahedron Letters, 1990, 31, 6231-6234
1.425Citations (PDF)
361Gly/Lys- containing peptide macrocycles: Synthesis and cyclization studies
Tetrahedron Letters, 1990, 31, 4191-4194
1.49Citations (PDF)
362Arenesulphonyltriazolides as condensing reagents in solid phasepeptide synthesis
Tetrahedron Letters, 1990, 31, 1915-1918
1.414Citations (PDF)
363Solid-phase approaches to regiospecific double disulfide formation. Application to a fragment of bovine pituitary peptide
Tetrahedron, 1990, 46, 8255-8266
2.033Citations (PDF)
364Optimization of the experimental procedures in fast atom bombardment mass spectrometry of peptides with a quadrupole mass spectrometer
Biological Mass Spectrometry, 1990, 19, 235-239
0.03Citations (PDF)
365Convenient Syntheses of Fluorenylmethyl-Based Side Chain Derivatives of Glutamic and Aspartic acids, Lysine, and Cysteine
Synthesis, 1990, 1990, 119-122
2.345Citations (PDF)
366Solid-phase-mediated peptide heterodisulfide formation15.021Citations (PDF)
367Determination of rotational barriers of carbon(sp2)-carbon(sp3) bonds in 2-arylpiperidines. 3. Proton dynamic nuclear magnetic resonance studies and molecular mechanics calculations of the 1,2,2-trimethyl-6-(3,4,5-trimethoxyphenyl)- and 1,5,5-trimethyl-2-(3,4,5-trimethoxyphenyl)-4-piperidones
Journal of Organic Chemistry, 1990, 55, 2307-2311
3.510Citations (PDF)
368A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C
Journal of General Virology, 1990, 71, 629-637
3.3205Citations (PDF)
369Application of acetamidomethyl and 9‐fluorenylmethyl groups for efficient side protection of penicillamine in solid‐phase peptide synthesis0.111Citations (PDF)
370Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture
Journal of Virology, 1990, 64, 5519-5528
3.7110Citations (PDF)
371A synthetic strategy for simultaneous purification-conjugation of antigenic peptides
Analytical Biochemistry, 1989, 181, 389-395
2.410Citations (PDF)
372Use of polystyrene-1% divinylbenzene and Kel-F-g-styrene for the simultaneous synthesis of peptides0.96Citations (PDF)
373Kinetic analyis of the carboxypeptidase a hydrolysis of oligopeptides by reversed-phase high-performance liquid chromatography
Journal of Chromatography A, 1989, 479, 27-37
3.73Citations (PDF)
374Convenient synthesis of a cyclic peptide disulfide: A type II β-turn structural model
Tetrahedron Letters, 1989, 30, 2441-2444
1.435Citations (PDF)
375Convergent solid phase peptide synthesis. VII. Good yields in the coupling of protected segments on a solid support
Tetrahedron, 1989, 45, 4637-4648
2.022Citations (PDF)
376Comparative study of supports for solid-phase coupling of protected-peptide segments
Journal of Organic Chemistry, 1989, 54, 360-366
3.552Citations (PDF)
377Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.7.6135Citations (PDF)
378Anchoring of Fmoc‐amino acids to hydroxymethyl resins0.137Citations (PDF)
379Use of the Npys thiol protection in solid phase peptide synthesis Application to direct peptide‐protein conjugation through cysteine residues0.152Citations (PDF)
38013C Dynamic Nmr Studies on Restricted Rotation about C-N Bond in 2-Aryl-1-formyl-4-piperidones
Heterocycles, 1989, 29, 2185
0.416Citations (PDF)
381Fast atom bombardment mass spectrometry of protected peptide segments1.713Citations (PDF)
382Molecular cloning of cDNAs encoding a putative cell wall protein from Zea mays and immunological identification of related polypeptides
Plant Molecular Biology, 1988, 11, 483-493
3.271Citations (PDF)
383Uteroglobin-like peptide cavities I. Synthesis of antiparallel and parallel dimers of bis-cysteine peptides
Tetrahedron Letters, 1988, 29, 3845-3848
1.434Citations (PDF)
384Steady-state dqf-cosy spectra using a variable relaxation delay0.73Citations (PDF)
385Use of polar picolyl protecting groups in peptide synthesis
Journal of Organic Chemistry, 1988, 53, 5386-5389
3.517Citations (PDF)
386Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease
Virus Research, 1987, 8, 261-274
2.6129Citations (PDF)
387Polymer bound pyrrole compounds- II
Tetrahedron, 1987, 43, 2593-2608
2.014Citations (PDF)
388Conformational analysis of the repeated sequence of glutelin-2, a maize storage protein1.412Citations (PDF)
389Convergent solid phase peptide synthesis. v. synthesis of the 1-4, 32-34, and 53-59 protected segments of the toxin ii of androctonus australis hector.
Tetrahedron, 1987, 43, 5961-5971
2.020Citations (PDF)
390Convergent solid phase peptide synthesis vi : synthesis by the fmoc procedure with a modified protocol of two protected segments, sequence 5-17 and 18-31 of the neurotoxin ii of the scorpion androctonus australis hector.
Tetrahedron, 1987, 43, 5973-5980
2.015Citations (PDF)
391Reversed-phase high-performance liquid chromatography of protected peptide segments
Journal of Chromatography A, 1987, 409, 281-290
3.76Citations (PDF)
392Molecular mechanics calculations on the Csp3-Csp2 rotation in the N,3,3-trimethyl-2-phenyl-4-piperidone system
Journal of Organic Chemistry, 1986, 51, 3951-3955
3.57Citations (PDF)
393(S)-9-Fluorenylmethyl-L-cysteine, a useful HF-stable derivative for peptide synthesis1.924Citations (PDF)
394Application of two-dimensional NMR spectroscopy to the study of the cyclic decapeptide antamanide1.47Citations (PDF)
395Convergent solid phase peptide synthesis IV.
Tetrahedron, 1986, 42, 6703-6711
2.017Citations (PDF)
396Convergent solid phase peptide synthesis-III
Tetrahedron, 1986, 42, 691-698
2.025Citations (PDF)
397Determination of rotational barriers of c(sp2)-c(sp3) bonds in 2-arylpiperidines. II.1 1h-dnmr and 13c-dnmr studies of the trans-1,3-dimethyl-2-(3,4,5-trimethoxyphenyl)-4-piperidone
Tetrahedron, 1986, 42, 3957-3966
2.015Citations (PDF)
398Diketopiperazine formation in solid phase peptide synthesis using p-alkoxybenzyl ester resins and Fmoc-amino acids
Tetrahedron Letters, 1986, 27, 743-746
1.4139Citations (PDF)
399Determination of the preferred tautomeric form of 4‐nitrohistidine2.29Citations (PDF)
400The relevance of imidazole tautomerism for the hormonal activity of histidine-containing peptides
Bioorganic Chemistry, 1986, 14, 405-416
4.212Citations (PDF)
401Conformational analysis of -2,3-diaryloxy-1,4-dioxanes. A tool for discriminating between steric and electronic effects in the position of
Tetrahedron, 1985, 41, 3785-3789
2.07Citations (PDF)
40213C-NMR spectra of fluorinated molecules using 19F-13C polarization transfer
Tetrahedron Letters, 1985, 26, 2817-2820
1.46Citations (PDF)
403Use of histidine pKa changes to study peptide-DNA interactions
Bioorganic Chemistry, 1985, 13, 171-178
4.22Citations (PDF)
404The Use of Nbb Resin in Cyclic Dipeptide ("Diketopiperazine") Synthesis
Synthesis, 1985, 1985, 181-184
2.314Citations (PDF)
405Application of gel-phase 13c-nmr to monitor solid phase peptide synthesis
Tetrahedron, 1984, 40, 4141-4152
2.0104Citations (PDF)
406Determination of rotational barriers of carboncarbon bonds in 2‐arylpiperidines2.215Citations (PDF)
407Polymer bound pyrrole compounds. Reversible anchoring of bilirubin and biliverdin to a polystyrene matrix
Tetrahedron Letters, 1984, 25, 4145-4146
1.49Citations (PDF)
408Solid phase synthesis of tyrosine-containing histone fragments
Tetrahedron, 1983, 39, 3185-3188
2.010Citations (PDF)
409Conformational analysis of 2,3-dialkoxy-1,4-dioxanes
Tetrahedron, 1983, 39, 3959-3963
2.011Citations (PDF)
410Determination of acid dissociation constants of histidine-containing peptides by proton magnetic resonance spectroscopy0.812Citations (PDF)
411Conformational basis of N-glycosylation of proteins: conformational analysis of Ac-Asn-Ala-Thr-NH28.24Citations (PDF)
412Convergent solid phase peptide synthesis. I. Synthesis of protected segments on a hydroxymethylphenyloxymethyl resin using the base labile FMOC α-amine protection. Model synthesis of LHRH.
Tetrahedron, 1982, 38, 1183-1192
2.046Citations (PDF)
413Convergent solid phase peptide synthesis. II. Synthesis of the 1–6 apamin protected segment on a NBB-resin. Synthesis of apamin
Tetrahedron, 1982, 38, 1193-1201
2.057Citations (PDF)
414Diketopiperazine formation in acetamido-and nitrobenzamido-bridgedpolymeric supports.
Tetrahedron Letters, 1981, 22, 3779-3782
1.443Citations (PDF)
415α-(Phenylacetamido)benzylpolystyrene (pab-resin)
Tetrahedron, 1981, 37, 2007-2010
2.012Citations (PDF)
416Acid-base properties of 4-nitro-l-histidine and related compounds
Bioorganic Chemistry, 1979, 8, 59-67
4.24Citations (PDF)
417Effect of trifluoroacetic acid upon Boc-aminoacyl- and Box-peptidyl-resins. Description of a new polymeric support for solid phase peptide synthesis.
Tetrahedron Letters, 1979, 20, 3587-3590
1.44Citations (PDF)
418Chromatographic determination of 4-nitro-l-histidine
Journal of Chromatography A, 1978, 151, 228-231
3.71Citations (PDF)
41936 Clinical phase I and II trial of cis platinum (CDDP) and preclinical and clinical phase I studies of malonato platinum (MDP)
Biochimie, 1978, 60, 1062
2.90Citations (PDF)
420A proton magnetic resonance study of isomeric alkylidencyanoesters0.83Citations (PDF)